C-V2EWCosmica Biosciences
AI, multi-omics, aging biomarkers
discoverydiscovering
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-V2EW
C-V2EWC-V2EWAI, multi-omics, aging biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cosmica Biosciences states that spaceflight exposures such as microgravity and radiation accelerate cellular and organismal aging, and that studying these changes can reveal biomarkers, rejuvenating mechanisms, and therapeutic targets that help extend human health and lifespan on Earth while also reducing the health risks of space exploration. The company presents space biology as a unique, underused way to speed human aging research and evaluate anti-aging interventions.
SourceCosmica Biosciences states that aging and space biology are deeply connected, arguing that the strong overlap between geriatric pathology and spaceflight pathology creates an underused opportunity to speed up human aging research and evaluate anti-aging therapeutics. The company further suggests that low gravity changes the pace of cellular and organismal aging, and that studying these effects could reveal biomarkers and interventions to extend healthspan and lifespan on Earth.
SourceCosmica Biosciences states that aging and spaceflight pathology overlap extensively, and that this creates an untapped opportunity to speed up human aging research and test anti-aging therapeutics. The company further asserts that low gravity changes the rate of cellular and organismal aging, and that studying these effects could reveal biomarkers and interventions to extend human health and lifespan on Earth.
Source